4ZY3
Crystal Structure of Keap1 in Complex with a small chemical compound, K67
4ZY3 の概要
| エントリーDOI | 10.2210/pdb4zy3/pdb |
| 分子名称 | Kelch-like ECH-associated protein 1, FORMIC ACID, N,N'-[2-(2-oxopropyl)naphthalene-1,4-diyl]bis(4-ethoxybenzenesulfonamide), ... (4 entities in total) |
| 機能のキーワード | nrf2, keap1, stress sensor, small molecule binding, double glycine repeat, kelch domain, p62, transcription |
| 由来する生物種 | Mus musculus (Mouse) |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 69797.64 |
| 構造登録者 | Fukutomi, T.,Iso, T.,Suzuki, T.,Takagi, K.,Mizushima, T.,Komatsu, M.,Yamamoto, M. (登録日: 2015-05-21, 公開日: 2016-05-25, 最終更新日: 2024-10-16) |
| 主引用文献 | Saito, T.,Ichimura, Y.,Taguchi, K.,Suzuki, T.,Mizushima, T.,Takagi, K.,Hirose, Y.,Nagahashi, M.,Iso, T.,Fukutomi, T.,Ohishi, M.,Endo, K.,Uemura, T.,Nishito, Y.,Okuda, S.,Obata, M.,Kouno, T.,Imamura, R.,Tada, Y.,Obata, R.,Yasuda, D.,Takahashi, K.,Fujimura, T.,Pi, J.,Lee, M.S.,Ueno, T.,Ohe, T.,Mashino, T.,Wakai, T.,Kojima, H.,Okabe, T.,Nagano, T.,Motohashi, H.,Waguri, S.,Soga, T.,Yamamoto, M.,Tanaka, K.,Komatsu, M. p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming Nat Commun, 7:12030-12030, 2016 Cited by PubMed Abstract: p62/Sqstm1 is a multifunctional protein involved in cell survival, growth and death, that is degraded by autophagy. Amplification of the p62/Sqstm1 gene, and aberrant accumulation and phosphorylation of p62/Sqstm1, have been implicated in tumour development. Herein, we reveal the molecular mechanism of p62/Sqstm1-dependent malignant progression, and suggest that molecular targeting of p62/Sqstm1 represents a potential chemotherapeutic approach against hepatocellular carcinoma (HCC). Phosphorylation of p62/Sqstm1 at Ser349 directs glucose to the glucuronate pathway, and glutamine towards glutathione synthesis through activation of the transcription factor Nrf2. These changes provide HCC cells with tolerance to anti-cancer drugs and proliferation potency. Phosphorylated p62/Sqstm1 accumulates in tumour regions positive for hepatitis C virus (HCV). An inhibitor of phosphorylated p62-dependent Nrf2 activation suppresses the proliferation and anticancer agent tolerance of HCC. Our data indicate that this Nrf2 inhibitor could be used to make cancer cells less resistant to anticancer drugs, especially in HCV-positive HCC patients. PubMed: 27345495DOI: 10.1038/ncomms12030 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.8 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






